Related references
Note: Only part of the references are listed.A Child With Dyserythropoietic Anemia and Megakaryocyte Dysplasia Due to a Novel 5UTR GATA1s Splice Mutation
Jacob Zucker et al.
PEDIATRIC BLOOD & CANCER (2016)
A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders
Ilenia Simeoni et al.
BLOOD (2016)
Paris-Trousseau: evidence keeps pointing to FLI1
Jorge Di Paola
BLOOD (2015)
From cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation
Tarik Moeroey et al.
BLOOD (2015)
Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1
William S. Stevenson et al.
BLOOD (2015)
Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis
Hiromitsu Iizuka et al.
EXPERIMENTAL HEMATOLOGY (2015)
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia
Leila Noetzli et al.
NATURE GENETICS (2015)
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia
Ileana Antony-Debre et al.
BLOOD (2015)
Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice
Jose A. Guerrero et al.
BLOOD (2014)
Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects
Jon P. Connelly et al.
BLOOD (2014)
Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets
A. C. Glembotsky et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
A Dominant-Negative GFI1B Mutation in the Gray Platelet Syndrome
Davide Monteferrario et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Transcriptional diversity during lineage commitment of human blood progenitors
Lu Chen et al.
SCIENCE (2014)
Spotlight on FLI1, RUNX1, and platelet dysfunction
A. Koneti Rao
BLOOD (2013)
Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects
Jacqueline Stockley et al.
BLOOD (2013)
Congenital Thrombocytopenia Clinical Manifestations, Laboratory Abnormalities, and Molecular Defects of a Heterogeneous Group of Conditions
Riten Kumar et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2013)
Inherited Platelet Function Disorders Overview and Disorders of Granules, Secretion, and Signal Transduction
A. Koneti Rao
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2013)
GFI1B mutation causes a bleeding disorder with abnormal platelet function
W. S. Stevenson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Transcription factors in late megakaryopoiesis and related platelet disorders
M. R. Tijssen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression
Dominique Bluteau et al.
BLOOD (2012)
MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations
Ileana Antony-Debre et al.
BLOOD (2012)
RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization
Larissa Lordier et al.
NATURE COMMUNICATIONS (2012)
被撤回的出版物: A BLOC-1 Mutation Screen Reveals that PLDN Is Mutated in Hermansky-Pudlak Syndrome Type 9 (Retracted article. See vol. 100, pg. 837, 2017)
Andrew R. Cullinane et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Platelet Protein Kinase C-θ Deficiency With Human RUNX1 Mutation PRKCQ Is a Transcriptional Target of RUNX1
Gauthami Jalagadugula et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Transcription factor networks in erythroid cell and megakaryocyte development
Louis C. Dore et al.
BLOOD (2011)
Genome-wide Analysis of Simultaneous GATA1/2, RUNX1, FLI1, and SCL Binding in Megakaryocytes Identifies Hematopoietic Regulators
Marloes R. Tijssen et al.
DEVELOPMENTAL CELL (2011)
Familial myelodysplastic syndromes: a review of the literature
Elena Liew et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Mechanism of platelet factor 4 (PF4) deficiency with RUNX1 haplodeficiency: RUNX1 is a transcriptional regulator of PF4
K. Aneja et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome
Walter H. A. Kahr et al.
NATURE GENETICS (2011)
Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome
Cornelis A. Albers et al.
NATURE GENETICS (2011)
NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules
Meral Gunay-Aygun et al.
NATURE GENETICS (2011)
Gfi-1B controls human erythroid and megakaryocytic differentiation by regulating TGF-β signaling at the bipotent erythro-megakaryocytic progenitor stage
Voahangy Randrianarison-Huetz et al.
BLOOD (2010)
RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency
Gurpreet Kaur et al.
BLOOD (2010)
Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency
Gauthami Jalagadugula et al.
BLOOD (2010)
Evidence that Growth factor independence 1b regulates dormancy and peripheral blood mobilization of hematopoietic stem cells
Cyrus Khandanpour et al.
BLOOD (2010)
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy
Carolyn J. Owen et al.
BLOOD (2008)
RUNX1 gene mutation in primary myelodysplastic syndrome -: the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome
Chien-Yuan Chen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Why the disorder induced by GATA1 Arg216Gln mutation should be called X-linked thrombocytopenia with thalassemia rather than X-linked gray platelet syndrome
Carlo L. Balduini et al.
BLOOD (2007)
X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation
Venee N. Tubman et al.
BLOOD (2007)
Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: insights from platelet expression profiling
L. Sun et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis
Luciana M. Hollanda et al.
NATURE GENETICS (2006)
Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet α-granule biogenesis
B Lo et al.
BLOOD (2005)
Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation
PG Heller et al.
BLOOD (2005)
Selective impairment of platelet activation to collagen in the absence of GATA1
SC Hughan et al.
BLOOD (2005)
Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1
GC Del Vecchio et al.
ACTA HAEMATOLOGICA (2005)
Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome
P Gissen et al.
NATURE GENETICS (2004)
AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis
M Ichikawa et al.
NATURE MEDICINE (2004)
Association of CBFA2 mutation with decreased platelet PKC-θ and impaired receptor-mediated activation of GPIIb-IIIa and pleckstrin phosphorylation:: proteins regulated by CBFA2 play a role in GPIIb-IIIa activation
LS Sun et al.
BLOOD (2004)
Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors
W Sun et al.
BLOOD (2004)
X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction
CN Yu et al.
BLOOD (2002)
In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis
J Michaud et al.
BLOOD (2002)
The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages
S Saleque et al.
GENES & DEVELOPMENT (2002)
Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation
K Freson et al.
HUMAN MOLECULAR GENETICS (2002)
X-linked thrombocytopenia caused by a novel mutation of GATA-1
MG Mehaffey et al.
BLOOD (2001)
Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation
K Freson et al.
BLOOD (2001)
Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1
KE Nichols et al.
NATURE GENETICS (2000)
Share Paper
